We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

U.S. FDA Accepts Licence For Biosimilar Trastuzumab

News   Jan 12, 2017 | Original Story From Biocon

 
U.S. FDA Accepts Licence For Biosimilar Trastuzumab
 
 
 

RELATED ARTICLES

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Discovery Could Help Treat People With Cardiovascular Disease

News

Researchers have found a link between a peptide called apelin and a reduction of abdominal aortic aneurysms that was shown to dramatically reduce mortality in mice. They are using this knowledge to develop a new medical therapy to treat cardiovascular disease.

READ MORE

Half of Ebola Outbreaks Go Undetected

News

The number of undetected Ebola outbreaks has been estimated, in a study published in PLOS Neglected Tropical Diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE